Abbott Laboratories (ABT)

Currency in USD
101.56
+0.51(+0.50%)
Closed·
101.74+0.18(+0.18%)
·

Abbott Labs (ABT) Earnings Dates & Reports

Latest Release
Jan 22, 2026
EPS / Forecast
1.50 / 1.50
Revenue / Forecast
11.46B / 11.8B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
03/2026--/1.15--/11.00B----Free Sign Up
12/20251.50/1.5011.46B/11.80B0%-2.88%Free Sign Up
09/20250.940/1.3011.37B/11.40B-27.69%-0.26%Free Sign Up
06/20251.26/1.2511.42B/11.07B+0.8%+3.16%Free Sign Up
03/20250.760/1.0710.36B/10.40B-28.97%-0.38%Free Sign Up
12/20241.34/1.3410.97B/11.03B0%-0.54%Free Sign Up
09/20241.21/1.2010.60B/10.56B+0.83%+0.38%Free Sign Up
06/20241.14/1.1110.38B/10.37B+2.7%+0.1%Free Sign Up
03/20240.980/0.9609.96B/9.89B+2.08%+0.71%Free Sign Up
12/20231.19/1.1910.24B/10.17B0%+0.69%Free Sign Up

All numbers in USD

Abbott Laboratories Earnings Call Summary for Q4/2025

  • Abbott Labs reported Q4 2025 EPS of $1.50 (meeting expectations) but missed revenue forecast with $11.46B, causing shares to drop 9.39% in pre-market trading
  • Despite revenue shortfall, Abbott achieved 3.8% sales growth excluding COVID testing, with adjusted operating margin increasing 150 basis points to 25.8%
  • For 2026, Abbott projects 6.5-7.5% organic sales growth and ~10% adjusted EPS growth ($5.55-$5.80), driven by planned product launches and expansion
  • Company announced plans to enter cancer diagnostics market through acquisition of Exact Sciences, reinforcing CEO Robert Ford's emphasis on innovation
  • Key challenges include supply chain disruptions, intense competition in CGM and diagnostics markets, and persistent issues in the nutrition business
Last Updated: 01/22/2026, 10:27 AM
Read Full Transcript
Abbott Labs investor slides for Q4/2025
Abbott Q4 2025 presentation slides
Last Update: Jan 22, 2026
See full investor slides

FAQ

What Is Abbott Labs's Earnings Per Share (TTM)?

The Abbott Labs EPS (TTM) is 3.72.

When Is The Next Abbott Labs Earnings Date?

Abbott Labs will release its next earnings report on Apr 16, 2026.

What Is Abbott Labs’s Revenue Forecasts For Upcoming Quarters?

Abbott Labs’s revenue forecast is 12.11B.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.